These markers included elevated HOMA-IR, HbA1c, and fasting blood glucose that indicated impaired glucose metabolism; elevated LDL-C and systolic blood pressure that were risk factors for cardiovascular events; total cholesterol, HDL-C, LDL-C, and triglyceride that were markers of dyslipidemia; elevated alanine aminotransferase for liver impairment; and elevated creatinine and urine microalbumin for renal impairment. This evidence concerns the gene GPT and metabolic syndrome.